skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 292  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Antineoplastic extravasation management: consensus of the Spanish Oncology Pharmacy Group (GEDEFO)
Material Type:
Article
Add to My Research

Antineoplastic extravasation management: consensus of the Spanish Oncology Pharmacy Group (GEDEFO)

Albert-Marí A, Jiménez-Pulido I, José-Ruiz BS, Conde-Estévez D, Gil-Lemus MÁ, Cercós-Lletí AC, et al. Antineoplastic extravasation management: consensus of the Spanish Oncology Pharmacy Group (GEDEFO), J Oncol Pharm Pract. 2022 Apr 26: 10781552221091914. Copyright © 2022. DOI: 10.1177/10781552221091914. info:eu-repo/semantics/openAccess ;ISSN: 1078-1552 ;EISSN: 1477-092X ;DOI: 10.1177/10781552221091914

Digital Resources/Online E-Resources

2
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper
Material Type:
Article
Add to My Research

Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper

cc by (c) Alberti, Paola et al., 2024 http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess ;ISSN: 1433-7339 ;EISSN: 1433-7339 ;DOI: 10.1007/s00520-023-08301-5

Digital Resources/Online E-Resources

3
A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer
Material Type:
Article
Add to My Research

A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

cc by (c) Nadal, Ernest et al., 2023 http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11153-1

Full text available

4
Therapy-induced senescence enhances the efficacy of HER2-targeted antibody-drug conjugates in breast cancer
Material Type:
Article
Add to My Research

Therapy-induced senescence enhances the efficacy of HER2-targeted antibody-drug conjugates in breast cancer

American Association for Cancer Research (AACR) http://dx.doi.org/10.1158/0008-5472.CAN-22-0787 info:eu-repo/semantics/openAccess ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-22-0787

Full text available

5
COUPY Coumarins as Novel Mitochondria-Targeted Photodynamic Therapy Anticancer Agents
Material Type:
Article
Add to My Research

COUPY Coumarins as Novel Mitochondria-Targeted Photodynamic Therapy Anticancer Agents

cc-by (c) Ortega-Forte, Enrique, et al., 2021 http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess ;ISSN: 0022-2623 ;EISSN: 1520-4804 ;DOI: 10.1021/acs.jmedchem.1c01254

Digital Resources/Online E-Resources

6
An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: Synthesis and photoactivation studies
Material Type:
Article
Add to My Research

An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: Synthesis and photoactivation studies

Chemical communications (Cambridge, England), 2015 [Peer Reviewed Journal]

Attribution 3.0 Spain info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/3.0/es/ ;ISSN: 1359-7345 ;EISSN: 1364-548X

Digital Resources/Online E-Resources

7
A Landscape of Pharmacogenomic Interactions in Cancer
Material Type:
Article
Add to My Research

A Landscape of Pharmacogenomic Interactions in Cancer

Cell, 2016-07, Vol.166 (3), p.740-754 [Peer Reviewed Journal]

2016 The Author(s) ;Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved. ;cc-by (c) Iorio, Francesco et al., 2016 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/3.0/es ;Attribution ;2016 The Author(s) 2016 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2016.06.017 ;PMID: 27397505

Full text available

8
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression
Material Type:
Article
Add to My Research

FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression

(c) American Society of Clinical Oncology, 2022 info:eu-repo/semantics/openAccess ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.02303

Full text available

9
Unexpected photoactivation pathways in a folate-receptor-targeted trans-diazido Pt(iv) anticancer pro-drug
Material Type:
Article
Add to My Research

Unexpected photoactivation pathways in a folate-receptor-targeted trans-diazido Pt(iv) anticancer pro-drug

(c) Gandioso, Albert et al., 2020 info:eu-repo/semantics/openAccess ;ISSN: 1477-9226 ;EISSN: 1477-9234 ;DOI: 10.1039/d0dt02577a

Digital Resources/Online E-Resources

10
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry
Material Type:
Article
Add to My Research

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry

Copyright © 2020 Cotes Sanchís et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, https://creativecommons.org/licenses/by/4.0/ which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0235848

Full text available

11
A potent fluorescent transmembrane HCl transporter perturbs cellular pH and promotes cancer cell death
Material Type:
Article
Add to My Research

A potent fluorescent transmembrane HCl transporter perturbs cellular pH and promotes cancer cell death

(c) Fares, M. et al., 2023 info:eu-repo/semantics/openAccess ;ISSN: 1477-0520 ;EISSN: 1477-0539 ;DOI: 10.1039/d3ob00128h

Digital Resources/Online E-Resources

12
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study
Material Type:
Article
Add to My Research

Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study

cc by-nc-nd (c) Moreno Arrones, O. M. et al., 2023 http://creativecommons.org/licenses/by-nc-nd/3.0/es/ info:eu-repo/semantics/openAccess ;ISSN: 0001-7310 ;DOI: 10.1016/j.ad.2023.04.022

Full text available

13
Iron Oxide Nanoparticles in Photothermal Therapy
Material Type:
Article
Add to My Research

Iron Oxide Nanoparticles in Photothermal Therapy

Molecules (Basel, Switzerland), 2018-06, Vol.23 (7), p.1567 [Peer Reviewed Journal]

2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;cc-by (c) Estelrich, Joan et al., 2018 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/3.0/es ;2018 by the authors. 2018 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules23071567 ;PMID: 29958427

Full text available

14
On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions
Material Type:
Article
Add to My Research

On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions

cc-by-nc-nd (c) Elsevier Ltd, 2016 http://creativecommons.org/licenses/by-nc-nd/3.0/es info:eu-repo/semantics/openAccess ;ISSN: 0968-0896 ;EISSN: 1464-3391 ;DOI: 10.1016/j.bmc.2016.09.037

Digital Resources/Online E-Resources

15
On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions
Material Type:
Article
Add to My Research

On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions

cc-by-nc-nd (c) Elsevier Ltd, 2016 http://creativecommons.org/licenses/by-nc-nd/3.0/es info:eu-repo/semantics/openAccess ;ISSN: 0968-0896 ;EISSN: 1464-3391 ;DOI: 10.1016/j.bmc.2016.09.037

Digital Resources/Online E-Resources

16
Global neurosurgery amongst the EANS community: where are we at?
Material Type:
Article
Add to My Research

Global neurosurgery amongst the EANS community: where are we at?

Copyright © 2022. Marchesini N, Ivanov M, Lafuente J, Sala F, Foroglou N, Visocchi M, et al. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess ;ISSN: 2772-5294 ;EISSN: 2772-5294 ;DOI: 10.1016/j.bas.2022.100911

Full text available

17
Inhibitors of lipogenic enzymes as a potential therapy against cancer
Material Type:
Article
Add to My Research

Inhibitors of lipogenic enzymes as a potential therapy against cancer

(c) The Federation of American Society of Experimental Biology, 2020 info:eu-repo/semantics/openAccess ;ISSN: 0892-6638 ;EISSN: 1530-6860 ;DOI: 10.1096/fj.202000705R

Full text available

18
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
Material Type:
Article
Add to My Research

Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma

Gut, 2017-03, Vol.66 (3), p.530-540 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;(c) Tovar, Victoria et al., 2017 info:eu-repo/semantics/openAccess ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2015-309501 ;PMID: 26658144 ;CODEN: GUTTAK

Full text available

19
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
Material Type:
Article
Add to My Research

Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma

(c) Tovar, Victoria et al., 2017 info:eu-repo/semantics/openAccess ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2015-309501

Full text available

20
Time‐dependent cytotoxic properties of terpyridine‐based copper complexes
Material Type:
Article
Add to My Research

Time‐dependent cytotoxic properties of terpyridine‐based copper complexes

(c) Wiley-VCH, 2020 info:eu-repo/semantics/openAccess ;ISSN: 1439-4227 ;EISSN: 1439-7633 ;DOI: 10.1002/cbic.202000154

Digital Resources/Online E-Resources

Results 1 - 20 of 292  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (131)

Refine My Results

Creation Date 

From To
  1. Before 2004  (6)
  2. 2004 To 2008  (27)
  3. 2009 To 2013  (63)
  4. 2014 To 2019  (149)
  5. After 2019  (52)
  6. More options open sub menu

Language 

  1. English  (224)
  2. Catalan  (46)
  3. Spanish  (23)
  4. Japanese  (9)
  5. More options open sub menu

Searching Remote Databases, Please Wait